The Stanford Neuro-Oncology Program Adult Clinical Trials

Recurrent High Grade Glioma

Phase II/III Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA
PI: Seema Nagpal NCT02414165

Phase Ib/II, Multicenter, Open-label Study of ACP-196 in Subjects with Recurrent Glioblastoma Multiforme (GBM)
PI: Lawrence Recht NCT02586857

A Phase I BPM31510 + Vitamin K in High Grade Glioma that has Recurred on Bevacizumab Containing Regimen
PI: Seema Nagpal NCT03020602

Brain Metastases

Phase II Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung CA / Metastatic Breast CA
PI: Joel Neal NCT02312622

A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients with ALK-Positive NSCLC Metastatic to the Brain and/or to Leptomeninges
PI: Joel Neal NCT02336451

Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients with Brain Metastases
PI: Scott Soltys NCT02360215

Clinical Trials

Stanford Cancer Institute offers leading edge research and compassionate care with over 250 actively recruiting clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.


Sophie Bertrand, CCRP
Clinical Research Manager / Neuro-Oncology / Head and Neck / Cancer Clinical Trials Office